Yanick J Crow Selected Research

Myositis (Idiopathic Inflammatory Myopathies)

1/2020	Circulating Interferon-α Measured With a Highly Sensitive Assay as a Biomarker for Juvenile Inflammatory Myositis Activity: Comment on the Article by Mathian et al.
1/2020	Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling.
8/2015	Mosaic Tetrasomy 9p: A Mendelian Condition Associated With Pediatric-Onset Overlap Myositis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanick J Crow Research Topics

Disease

11	Bites and Stings (Sting) 01/2022 - 12/2014
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 06/2008
7	Infections 01/2018 - 08/2006
5	Cysts 12/2021 - 10/2016
5	Dermatomyositis (Dermatopolymyositis) 01/2021 - 11/2016
5	Leukoencephalopathies 01/2021 - 10/2016
4	Hemorrhage 01/2022 - 01/2019
4	Virus Diseases (Viral Diseases) 01/2022 - 01/2017
4	Inflammation (Inflammations) 01/2019 - 01/2015
4	Autoimmune Diseases (Autoimmune Disease) 04/2016 - 07/2012
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2020 - 08/2015
3	Spondyloenchondrodysplasia 01/2017 - 11/2011
2	chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature 01/2022 - 01/2022
2	Vasculitis (Vasculitides) 01/2022 - 01/2022
2	Cerebroretinal Microangiopathy with Calcifications and Cysts 12/2021 - 01/2020
2	Retinal Telangiectasis 12/2021 - 06/2017
2	Pancytopenia 12/2021 - 02/2011
2	Telangiectasis (Telangiectasia) 12/2021 - 06/2017
2	COVID-19 10/2021 - 01/2021
2	Pneumonia (Pneumonitis) 01/2021 - 01/2021
2	Anemia 01/2020 - 02/2011
2	Nervous System Diseases (Neurological Disorders) 01/2020 - 12/2016
2	Brain Diseases (Brain Disorder) 11/2011 - 01/2009
1	Disease Progression 02/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Lupus Nephritis 01/2022
1	Portal Hypertension 12/2021
1	Metabolic Bone Diseases (Osteopenia) 12/2021
1	Neuroinflammatory Diseases 12/2021
1	Systemic Scleroderma (Systemic Sclerosis) 10/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Human Influenza (Influenza) 10/2021
1	Thrombosis (Thrombus) 10/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Leukoencephalopathy Brain Calcifications and Cysts 11/2020
1	Spastic Ataxia 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Arthritis (Polyarthritis) 01/2020
1	Genomic Instability 01/2020
1	Optic Atrophy 01/2020
1	Hepatopulmonary Syndrome 01/2019
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2019
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2019
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2019
1	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 01/2018
1	Joint Diseases (Joint Disease) 12/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2017
1	Hematologic Diseases (Blood Diseases) 12/2017
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 12/2017
1	Neonatal Anemia 12/2017
1	Papilledema 06/2017
1	Hypokinesia (Bradykinesia) 06/2017
1	Diabetes Mellitus 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Atrophy 12/2016
1	Leukocytosis (Pleocytosis) 12/2016
1	Cerebral Small Vessel Diseases 10/2016

Drug/Important Bio-Agent (IBA)

21	InterferonsIBA 01/2022 - 04/2011
11	Interferon Type IIBA 01/2021 - 10/2009
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
5	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2021 - 12/2014
5	AutoantibodiesIBA 01/2021 - 10/2015
5	Nucleic AcidsIBA 01/2021 - 06/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2014
4	Retinaldehyde (Retinal)IBA 12/2021 - 04/2015
4	CytokinesIBA 10/2021 - 11/2011
3	Small Nucleolar RNA (snoRNA)IBA 01/2021 - 10/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2022
2	Bevacizumab (Avastin)FDA Link 11/2020 - 06/2017
2	AntibodiesIBA 01/2019 - 08/2015
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2017
2	Tartrate-Resistant Acid PhosphataseIBA 01/2017 - 02/2011
2	Antiviral Agents (Antivirals)IBA 09/2013 - 11/2011
2	Ribonucleases (Ribonuclease)IBA 07/2012 - 08/2006
1	Janus Kinase InhibitorsIBA 02/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Adenosine DeaminaseIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 10/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	ChemokinesIBA 10/2021
1	Rheumatoid FactorIBA 01/2021
1	Coatomer Protein (Archain)IBA 11/2020
1	Polynucleotide Adenylyltransferase (Polymerase, Poly A)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Shelterin ComplexIBA 01/2020
1	tert-butylserineIBA 01/2019
1	ruxolitinibIBA 11/2018
1	AIRE ProteinIBA 01/2018
1	Antinuclear AntibodiesIBA 12/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2017
1	BX795IBA 01/2017
1	Amino Acids FDA Link 01/2017
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2017
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2016

Therapy/Procedure

2	Therapeutics 01/2022 - 06/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Aftercare (After-Treatment) 06/2017